Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1266-8
Published Online: 2016-03-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Häge, Alexander
Banaschewski, Tobias
Buitelaar, Jan K.
Dijkhuizen, Rick M.
Franke, Barbara
Lythgoe, David J.
Mechler, Konstantin
Williams, Steven C. R.
Dittmann, Ralf W.